After underperforming the overall market for the past few years, large-cap pharmaceutical stocks may now be positioned to ...

Mild and moderate infections are common among patients with inflammatory bowel disease, with women having higher incidence rates than men.

A head-to-head comparison of the JAK inhibitor drug tofacitinib and chimeric monoclonal antibody infliximab in the treatment of acute severe ulcerative colitis (ASUC) shows that, contrary to ...

People of color with inflammatory bowel disease aren’t getting access to the same level of care as their white peers, a new study shows.

Key messages • Remote care is probably the same as usual care (e.g. face-to-face care in clinics and hospitals) for improving inflammatory bowel disease symptoms in adults; there is limited evidence ...